Electra Therapeutics, Inc. (ETRA)
NASDAQ: ETRA · Real-Time Price · USD
7.71
-0.36 (-4.46%)
Nov 4, 2026, 1:58 PM EST - Market open

Electra Therapeutics Statistics

Total Valuation

ETRA has a market cap or net worth of $483.93 million. The enterprise value is $388.19 million.

Market Cap483.93M
Enterprise Value 388.19M

Important Dates

The next estimated earnings date is Sunday, November 22, 2026, before market open.

Earnings Date Nov 22, 2026
Ex-Dividend Date n/a

Share Statistics

ETRA has 62.77 million shares outstanding.

Current Share Class 62.77M
Shares Outstanding 62.77M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.37%
Owned by Institutions (%) 2.09%
Float 29.91M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.83
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.37, with a Debt / Equity ratio of 0.02.

Current Ratio 7.37
Quick Ratio 7.19
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -78.44

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -93.41%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$2.07M
Employee Count 46
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 29.93
Average Volume (20 Days) 365,653

Short Selling Information

The latest short interest is 409,380, so 0.65% of the outstanding shares have been sold short.

Short Interest 409,380
Short Previous Month 702,266
Short % of Shares Out 0.65%
Short % of Float 1.37%
Short Ratio (days to cover) 0.51

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -86.75M
Pretax Income -85.53M
Net Income -95.20M
EBITDA n/a
EBIT -86.75M
Earnings Per Share (EPS) -$2,163.66
Full Income Statement

Balance Sheet

The company has $97.73 million in cash and $1.98 million in debt, with a net cash position of $95.74 million or $1.53 per share.

Cash & Cash Equivalents 97.73M
Total Debt 1.98M
Net Cash 95.74M
Net Cash Per Share $1.53
Equity (Book Value) 91.72M
Book Value Per Share -4,987.61
Working Capital 86.74M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$74.68 million and capital expenditures -$644,000, giving a free cash flow of -$75.32 million.

Operating Cash Flow -74.68M
Capital Expenditures -644,000
Depreciation & Amortization 183,000
Net Borrowing n/a
Free Cash Flow -75.32M
FCF Per Share -$1.20
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ETRA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -28,063.02%
FCF Yield -17.00%

Analyst Forecast

The average price target for ETRA is $33.20, which is 330.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target $33.20
Price Target Difference 330.61%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1